Latest Commercialization News

SSH Mining Australia has entered a profit share mining agreement with High-Tech Metals to advance the Wagtail Gold Deposit, marking a pivotal step in the Mt Fisher Gold Project's development.

Island Pharmaceuticals has formally requested a Type C meeting with the US FDA to discuss accelerating approval of its antiviral Galidesivir for Marburg virus using the Animal Rule pathway.

Fenix Resources has locked in exclusive 30-year mining rights over a 290 million tonne iron ore resource at the Weld Range Project, significantly extending its mine life and production capacity. This strategic partnership with Sinosteel Midwest and Baowu Steel Group positions Fenix for ambitious growth in Western Australia's Mid-West.

Metal Powder Works has achieved a key validation milestone for its commercially pure titanium powder, confirming performance on par with industry benchmarks for cold spray applications. This breakthrough positions MPW to expand into the lucrative aerospace and advanced manufacturing markets.

Osteopore Limited has established OsteoRx, a new special purpose vehicle, with an initial AUD 0.5 million investment to accelerate breakthroughs in cellular regenerative medicine. This strategic move integrates a controlling stake in US-based RxCell Inc, expanding Osteopore’s footprint in the fast-growing stem cell market.

4DMedical Limited has secured FDA clearance for CT – VQ™, the first non-contrast CT-based ventilation-perfusion imaging technology, promising to transform lung diagnostics by replacing traditional nuclear scans.

Activeport Group launches Asia’s inaugural software-orchestrated Network-to-Network Interconnect Exchange in Singapore, integrating Megaport’s global data centre connectivity to transform cross-border telecom services.

Botanix Pharmaceuticals posted a sharp revenue increase driven by its new hyperhidrosis treatment Sofdra, yet reported a substantial net loss reflecting heavy investment in commercialisation. The company’s strong cash position underpins its path to profitability.

Nanoveu Limited’s transformative half-year report highlights its EMASS acquisition, executive hires, and technology advances amid a $3 million loss and new US OTCQB listing.

RLF AgTech Ltd has reported a remarkable financial turnaround in FY25, with revenues more than doubling and losses narrowing significantly, setting the stage for expansion in FY26.

FBR Ltd reported a 57% revenue increase driven by property sales but posted a $29 million loss as it advances commercialization of its Hadrian X® robotic bricklayer and secures significant new funding.

Delorean Corporation reveals a strategic shift from EPC contractor to owner-operator of bioenergy assets, unveiling a $500 million-plus project portfolio despite a FY25 revenue dip and loss. The company is positioning itself at the forefront of Australia’s renewable gas market.